Vemurafenib-induced pancreatitis in a patient with recurrent hairy cell leukaemia

Recent studies have shown that BRAF inhibitors, such as vemurafenib, are effective in inducing long periods of remission in relapsed hairy cell leukaemia. Acute pancreatitis is one of the rare complications that is reported with vemurafenib use. As severe pancreatitis can be life threatening, physic...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMJ Case Rep
Asıl Yazarlar: Chung, Su Yun, Shen, Janice Gloria, Ghiuzeli, Cristina M
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2020
Konular:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7490934/
https://ncbi.nlm.nih.gov/pubmed/32928833
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-236073
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller